Top compounds associated with response to MEIS3


Feature Type Standardized
Nominal ANOVA
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.074 0.02
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC 0.098 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.02
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.02
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.077 0.02
mRNA CIL56 CTRPv2 pan-cancer AAC 0.12 0.02
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.087 0.03
mRNA ML239 CTRPv2 pan-cancer AAC 0.091 0.03
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.03
Download CSV